Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/26 17:12 | 1/27/26 | SERA | Health | Health | Medical Laboratories | Harrison Robert Gardner | UT | O | CIO | 4 | S | -20 | 3.00 | 0 | -7 | 87 | D | |||||||||||||||
12/11/25 19:58 | 12/10/25 | SERA | Health | Health | Medical Laboratories | Lindgardt Zhenya | UT | DO | CEO | 2 | S | -100 | 3.07 | 0 | -32 | 768 | D | |||||||||||||||
12/11/25 19:57 | 12/10/25 | SERA | Health | Health | Medical Laboratories | Kearney Paul | UT | O | Chief Da | 5 | S.d | -161 | 2.31 | 0 | -70 | 169 | D | |||||||||||||||
12/11/25 19:57 | 12/10/25 | SERA | Health | Health | Medical Laboratories | Jackson Benjamin | UT | O | GC | 1 | S | -3 | 3.31 | 0 | -1 | 119 | D | |||||||||||||||
12/11/25 19:56 | 12/10/25 | SERA | Health | Health | Medical Laboratories | Boniface John J. | UT | O | Chief Sc | 1 | S | -4 | 3.31 | 0 | -1 | 150 | D | |||||||||||||||
12/11/25 19:56 | 12/10/25 | SERA | Health | Health | Medical Laboratories | Aerts Austin | UT | O | CFO | 2 | S | -19 | 3.08 | 0 | -6 | 273 | D | |||||||||||||||
12/8/25 19:06 | 12/8/25 | SERA | Health | Health | Medical Laboratories | Lawrence Sandra Aj | UT | D | 1 | S | -5 | 3.05 | 0 | -2 | 20 | D | ||||||||||||||||
12/5/25 17:25 | 12/5/25 | SERA | Health | Health | Medical Laboratories | Mirza Mansoor Raza | UT | D | 1 | S | -1 | 3.05 | 0 | 0 | 58 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |